FoxO1: mute for a tuned metabolism?

被引：14
作者：
Cheng, Zhiyong [1 ]
机构：
[1] Virginia Tech, Dept Human Nutr Foods & Exercise, Fralin Translat Obes Res Ctr, Coll Agr & Life Sci, Blacksburg, VA 24061 USA
来源：
TRENDS IN ENDOCRINOLOGY AND METABOLISM | 2015年 / 26卷 / 08期
关键词：
FoxO1; insulin signaling; insulin resistance; glucose; lipid; metabolic homeostasis; HEPATIC GLUCOSE; IN-VIVO; INSULIN; LIVER;
D O I：
10.1016/j.tem.2015.06.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The transcription factor forkhead box O1 (FoxO1) plays pleiotropic roles in insulin-mediated glucose and lipid metabolism. In the liver, glucose production is finely controlled by insulin signaling that dampens FoxO1. Two recent studies show that silencing of FoxO1 is also essential for extra-hepatic insulin signaling to maintain glucose homeostasis.
引用
收藏
页码：402 / 403
页数：2
相关论文
共 10 条
  • [1] The AKTion in non-canonical insulin signaling
    Cheng, Zhiyong
    White, Morris F.
    [J]. NATURE MEDICINE, 2012, 18 (03) : 351 - 353
  • [2] Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models
    Cheng, Zhiyong
    White, Morris F.
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2011, 14 (04) : 649 - 661
  • [3] Foxo1 integrates insulin signaling with mitochondrial function in the liver
    Cheng, Zhiyong
    Guo, Shaodong
    Copps, Kyle
    Dong, Xiaochen
    Kollipara, Ramya
    Rodgers, Joseph T.
    Depinho, Ronald A.
    Puigserver, Pere
    White, Morris F.
    [J]. NATURE MEDICINE, 2009, 15 (11) : 1307 - U105
  • [4] A Mutant Allele Encoding DNA Binding-Deficient FoxO1 Differentially Regulates Hepatic Glucose and Lipid Metabolism
    Cook, Joshua R.
    Matsumoto, Michihiro
    Banks, Alexander S.
    Kitamura, Tadahiro
    Tsuchiya, Kyoichiro
    Accili, Domenico
    [J]. DIABETES, 2015, 64 (06) : 1951 - 1965
  • [5] Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation
    Dong, Xiaocheng C.
    Copps, Kyle D.
    Guo, Shaodong
    Li, Yedan
    Kollipara, Ramya
    DePinho, Ronald A.
    White, Morris F.
    [J]. CELL METABOLISM, 2008, 8 (01) : 65 - 76
  • [6] Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
    Lu, Mingjian
    Wan, Min
    Leavens, Karla F.
    Chu, Qingwei
    Monks, Bobby R.
    Fernandez, Sully
    Ahima, Rexford S.
    Ueki, Kohjiro
    Kahn, C. Ronald
    Birnbaum, Morris J.
    [J]. NATURE MEDICINE, 2012, 18 (03) : 388 - U254
  • [7] Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
    Nagashima, Takeyuki
    Shigematsu, Nobuharu
    Maruki, Riyo
    Urano, Yasuharu
    Tanaka, Hirotsugu
    Shimaya, Akiyoshi
    Shimokawa, Teruhiko
    Shibasaki, Masayuki
    [J]. MOLECULAR PHARMACOLOGY, 2010, 78 (05) : 961 - 970
  • [8] FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization
    O-Sullivan, Insug
    Zhang, Wenwei
    Wasserman, David H.
    Liew, Chong Wee
    Liu, Jonathan
    Paik, Jihye
    DePinho, Ronald A.
    Stolz, Donna Beer
    Kahn, C. Ronald
    Schwartz, Michael W.
    Unterman, Terry G.
    [J]. NATURE COMMUNICATIONS, 2015, 6
  • [9] Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
    Titchenell, Paul M.
    Chu, Qingwei
    Monks, Bobby R.
    Birnbaum, Morris J.
    [J]. NATURE COMMUNICATIONS, 2015, 6
  • [10] Targeting FoxO1 with AS1842856 Suppresses Adipogenesis
    Zou, Peng
    Liu, Longhua
    Zheng, Louise
    Liu, Lu
    Stoneman, Rebecca E.
    Cho, Alicia
    Emery, Ashley
    Gilbert, Elizabeth R.
    Cheng, Zhiyong
    [J]. CELL CYCLE, 2014, 13 (23) : 3759 - 3767
1